Allergy rescue film setback: FDA flags Anaphylm packaging, eyed for Q3 2026 - Stock Titan
FDA letter targets Anaphylm’s human-factor issues, not drug data. Aquestive plans HF and PK studies, Q3 2026 resubmission and Europe, Canada filings.
Search Group
Share To
Comments
About Screade
Screade® Inc. version c2ebf08, copyright 2016 - 2026
Blocked Users
Customize Dark Theme
Forgot your password?
Forgot your password?
Invite your friends
Please type emails of people you want to invite, we will send them invitation email on your behalf. Separate emails with comma if you want to invite multiple friends.
Comments